Call Us Today:
949.200.1600

Atypical Melanocytic Lesions

Home > Diagnosis > Melanoma > Atypical Melanocytic Lesions

Treatment for Atypical Melanocytic Lesions

ABOUT ATYPICAL MELANOCYTIC LESIONS

Atypical melanocytic lesions are also known as atypical melanocytic hyperplasia, atypical mole, or dysplastic mole. The majority of these are benign, however, some have a significant risk of developing into melanoma or actually being a melanoma. This terminology is applied based on either a visual inspection or a biopsy of the lesion.

ATYPICAL MELANOCYTIC LESIONS DIAGNOSED WITH VISUAL INSPECTION

Visual examination of skin can often identify suspicious lesions requiring further evaluation. Five visual characteristics are used to identify the risk of invasive melanoma:

 

A - asymmetry of lesion shape

B - borders that are irregular or blurred

C - color that is variable within a single lesion or different from other moles

D - diameter greater than 6 mm

E - evolution of a mole's appearance - size, color, or shape

 

These are indicators for  a biopsy to rule out melanoma.

ATYPICAL MELANOCYTIC LESION DIAGNOSED ON A BIOPSY

Atypical melanocytic lesions are pigmented moles that have been found to have abnormal cells and are assumed to be at risk for developing into a malignant melanoma. These lesions, once diagnosed as atypical, are typically excised to eliminate the risk of cancer. Although this seems like a prudent approach, scientific evidence for this is frequently lacking. Rationale for excision is based on clinical standards for treating melanoma-in-situ or lentigo maligna.

 

There are three levels of classification of atypical melanocytic lesions:

  • mild atypia in a melanocytic lesion
  • moderate atypia in a melanocytic lesion
  • severe atypia in a melanocytic lesion

 

Most pathologists regard mild and moderate atypia synonymously.

 

Only melanoma-in-situ has adequate evidence to support surgical excision. This particular lesion carries a 5-10% risk of degenerating into malignant melanoma over a 50 year lifetime. This breaks down to a risk of 1-2% per decade. What no one knows is the risk of the atypical melanocytic lesions. Logic would dictate that the risk would be even lower - if present at all.

 

The complete diagnosis of a melanocytic lesion requires a complete excision. These lesions frequently exhibit heterogeneity - variability of abnormality. In other words a lesion with moderate atypia may contain areas of melanoma-in-situ within it. Melanoma-in-situ lesion may contain areas of invasive malignant melanoma. Frequently, this variability is visible with a naked eye and guides clinical decision making.

 

The controversy arises when a biopsy is read as atypical melanocytic lesion with involved margins, and the pathologist recommends additional margin excision. From pathologist's perspective only a complete lesion removal allows for a definitive diagnosis. Complete excision of these atypical melanocytic lesions requires 2 mm margins around the visible lesion for complete clearance. Although most surgeons will not hesitate to excise these lesions completely, scientific evidence to support such approach is lacking. There little evidence that incomplete excision and subsequent lesion recurrence exposes the patient to a greater invasive melanoma risk.  Furthermore, cosmetic considerations may be significant in sensitive areas such as the nose or eyelids. Additional 2 mm margins on all sides of the lesion can drastically change the reconstruction and the outcome. So, each patient and each lesion musts be treated with individual considerations and not necessarily rigid protocols.

 

For in depth discussion of the risks of atypical nevi read this article.

 

Related Articles

Wood’s Lamp Lower Eyelid Melanoma in situ
HISTORY A 57-year-old woman presents with two year hisory of right under-eye pigmentation. Shave biopsy by an outside office diagnosed MMIS, lentigo maligna type. Evaluated under Wood’s Lamp. Patient will be getting treatment at an outside office. DISCUSSION Evaluation of pigmented lesions with blue light There are multiple aspects to evaluating pigmented lesions, the most…
Read More
Treatment Considerations for Melanoma In-Situ
HISTORY A 22-year-old woman presented with left upper lip lesion. Tape testing showed positive for LINC00518 and PRAME. Excisional biopsy was performed showing atypia on the preliminary results. DISCUSSION Management of melanoma in-situ can be especially challenging in cosmetically sensitive areas such as the lip. Traditional management options for melanoma in-situ include surgical excision, topical…
Read More
Managing Lentigo Maligna Melanoma
HISTORY A 56-year-old man presented with complaint of lifelong history of darkening, growing left lesion of the left cheek. Biopsy on 09/24/21 showed melanoma in-situ. Excision with 5-6mm margins and closure of left cheek melanoma performed on 12/2/21 showed positive margins at 3-4 o’clock margins. Woods lamp evaluation and re-excision performed on 1/7/22. DISCUSSION Lentigo…
Read More
A Modern Test for Melanoma
DecisionDx Melanoma is enhancing medical decision making in invasive melanoma stages I, II, and III.. Management of cutaneous melanoma involves strategic risk assessment and oncologic work-up. This typically includes staging, wide local excision, and possible sentinel lymph node biopsy or biologic therapy.  Traditionally, surgeons perform a sentinel lymph node biopsy (SLNB) if the possibility of…
Read More
Severe Lichenoid Drug Eruption from Pembrolizumab
HISTORY An 88-year-old woman with a six-month history of a diffuse, pruritic eruption that includes thick, hypertrophic leg lesions with accompanying edema, ulcerations, weeping exudates and pain. The eruption started during a course of pembrolizumab (keytruda) infusions for high risk melanoma of the left great toe. Last Keytruda infusion was three months ago. DISCUSSION  Pembrolizumab,…
Read More
Desmoplastic / Spindle Cell Melanoma of the Scalp
A 67-year-old man with CLL presents with 3 month h/o 3 cm dense dermal growing scalp mass. Incisional biopsy showed spindle cell melanoma. The tumor was resected with a 2 cm margin. Final pathology showed malignant melanoma—spindle cell / desmoplastic type. Additional 1.2 cm margin was resected for wide clearance creating a 10 x 9…
Read More

STAY UP TO DATE

Receive research updates, inspiring stories, healthy living tips and more.

Something went wrong. Please check your entries and try again.

FOLLOW US

ELEVATING THE STANDARDS OF SKIN CANCER MANAGEMENT.

© 2018 SCARS Management Services. All rights reserved.